Noninvasive Chromosomal Screening for Embryo Selection Trial

NCT04732013 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2022-04-21

No results posted yet for this study

Summary

To determine the diagnostic accuracy of non-invasive preimplantation genetic testing for aneuploidy (NI-PGT-A) for embryo selection.

Conditions

Interventions

OTHER

No clinical intervention is planned; study is observational

No intervention

Sponsors & Collaborators

  • Thermo Fisher Scientific, Inc

    collaborator INDUSTRY
  • Sequence46

    collaborator UNKNOWN
  • Olive Fertility Centre

    lead OTHER

Principal Investigators

  • Gary Nakhuda, MD · Olive Fertility Centre

Eligibility

Min Age
21 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-04
Primary Completion
2022-09-04
Completion
2022-12-04

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04732013 on ClinicalTrials.gov